Skip to main content
. Author manuscript; available in PMC: 2017 Oct 17.
Published in final edited form as: Vaccine. 2016 Sep 21;34(44):5225–5234. doi: 10.1016/j.vaccine.2016.09.016

Fig. 1. Construction of anti-Leishmania vaccine antigens used for ex vivo stimulation of canine whole blood.

Fig. 1

L111f is an 111kD fusion protein produced from a fusion of the L. major homologue of eukaryotic thiolspecific antioxidant (TSA), the L. major stress inducible protein-1 (LmSTI1) and the L. braziliensis elongation and initiation factor (LeIF) genes. NS is a 75kD fusion protein produced from the L. infantum nucleoside hydrolase (NH) and L. infantum sterol 24-c-methyltransferase (SMT) genes.